BANGKOK (The Nation/Asia News Network): Thailand has approved the manufacture of a Covid antibody nasal spray, making it the first in the world.
The spray - jointly developed by Chulalongkorn University, Silpakorn University, the Health Systems Research Institute (HSRI), the Government Pharmaceutical Organisation (GPO) and Hibiocy Co Ltd, an affiliate of Roujukiss International PCL or KISS - was launched at a special event at Samyan Mitrtown Hall on Wednesday (Sept 28).
The antibody-based nasal spray serves as a shield in protecting against Covid-19.
The breakthrough by the universities was transferred to the private sector which carried out clinical research to meet the standards needed for registration with the Thai FDA.
The antibodies created to make the spray have already been patented.
They have been used to make an antibody-based nasal spray sold under the trade name “Vaill CoviTRAP Anti-CoV Nasal Spray”, making Thailand the first country in the world to approve the commercial manufacture of the spray.
